Day: December 23, 2020

Jaguar Health Signs Second Agreement for $6 Million Non-dilutive Financing Transaction Involving the Sale of Royalty Rights Related to Future Mytesi (Crofelemer) and Lechlemer Revenue Stream

No royalty payments due for 18-24 months Proceeds will be allocated to support regulatory activities associated with the Company's development...

error: Content is protected !!